To determine the mechanisms by which AT2R regulates AML development, we analyzed genome-wide transcriptome changes in Agtr2+/+ versus Agtr2o/e MLL-AF9 AML cells. The gene discussed is KMT2A; the disease is acute myeloid leukemia.